Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT-1: Avatrombopag for Thrombocytopenia in Chronic Liver Disease
NCT01972529Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of avatrombopag in Thrombocytopenia, sponsored by Eisai Co., Ltd.. Started Feb 2014; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01972529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972529.